期刊文献+

卡前列素氨丁三醇防治宫缩乏力性产后出血的临床观察 被引量:30

Clinical observation of carboprost tromethamine in the prenventive treatment of uterine atony postpartum hemorrhage
暂未订购
导出
摘要 目的观察卡前列素氨丁三醇治疗宫缩乏力性产后出血的临床效果。方法将65例宫缩乏力性产后出血患者随机分为治疗组16例和对照组49例。胎儿娩出后,2组均予子宫按摩,并应用缩宫素40U及米索前列醇0.4mg,治疗组在此基础上予卡前列素氨丁三醇250μg于三角肌肌内注射。观察2组用药前后出血情况。结果用药后2组出血量均少于用药前,但治疗组出血量减少值高于对照组,差异均有统计学意义(P<0.01)。结论卡前列素氨丁三醇是强效而安全的宫缩剂,对于宫缩乏力性产后出血具有显著疗效。 Objective To observe the clinical efficacy of uterine atony carboprost tromethamine in the prenventive treatment of postpartum hemorrhage.Methods 65 cases patients with uterine atony postpartum hemorrhage were randomly divided into treatment group(16 cases) and control group(49 cases).After the baby was delivered,both groups were given uterine massage,and oxytocin 40U and misoprostol 0.4mg,treatment group,on basis of that,were given carboprost tromethamine 250ug deltoid intramuscular injection.Observed the postpartum hemorrhage situation of 2 groups.Results After treatment,the postpartum hemorrhage volume of 2 groups were less than before treatment,and postpartum hemorrhage decrease volume of treatment group was higher than that of control group,the difference was statistically significant(P 0.01).Conclusion Carboprost tromethamine is a potent and safe tocolytic agents,has significant effect on uterine atony postpartum hemorrhage.
作者 陈茜
出处 《临床合理用药杂志》 2013年第16期42-43,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 产后出血 宫缩乏力性 卡前列素氨丁三醇 米索前列醇 Postpartum hemorrhage uterine atony Carboprost tromethamine Misoprostol
  • 相关文献

参考文献2

二级参考文献3

共引文献124

同被引文献237

  • 1段玉珍,肖立英.产后子宫收缩乏力性出血的临床诊断和治疗[J].中国现代药物应用,2010,12(8):102-104.
  • 2Lovold A,Stanton C ,Armbuser D,et d.How to avoid iat-mgenic morbidity and mortality increasing availability of oxytocin and mispmstol for PPH prevention? [J].Int J Gy- naecol Obstet, 2008,103 (3) : 276-282.
  • 3Rajan, Priya V, Deborah A.Postpartum hemorrhage : evi- dence-based medical interventions for prevention and treatment[J].Clin Obstet Gynecol, 2010,53 ( 1 ) : 165-181.
  • 4Kalinka J, Lipifiska M, Sosnowski D,et al.Evaluation of carbetocin (pabal) efficacy in the prevention of the post- partum hemorrhage in women after cesarean section-pre- liminary report[J].Ginekol Pol, 2009,80 (7) : 512-517.
  • 5ACOG Publications. ACOG Practice Bulletin No. 76: Postpartum hemorrhage [J]. Obstet Gynecol, 2006, 108 (3) : 1039-1047.
  • 6谢幸,苟文丽主编.妇产科学[M].第8版,北京:人民卫生出版社,2010:34-45.
  • 7Bai J,Sun Q,Zhai H. A comparison of oxytocin and carbo- prost tromethamine in the prevention of postpartum hemor- rhage in high risk patients undergoing cesarean delivery [J]. Experimental and Therapeutic Medicine, 2014,7 ( 1 ) : 46- 50.
  • 8Chanhan D, Bhavsar M. Comparison of ramosetron and on- dansetron for prevention of nausea and vomiting after car- boprost in LSCS patients under spinal anesthesia [J]. In- ternational Journal of Reproduction, Contraception,Ob- stetrics and Gynecology,2014,3(3) :581-584.
  • 9Gibbins KJ,Albright CM,Rouse DJ. Postpartum hemorrhage in the developed world:whither misoprostol? [J]. American Journal of Obstetrics And Gynecology,2013,208(3) : 181- 183.
  • 10Kovaeheva VP, Soens MA,Tsen L C. Serum uric acid as a novel marker for uterine atony and post-spinal vasopressor use during cesarean delivery [J]. International Journal of Obstetric Anesthesia,2013,22(3) :200-208.

二级引证文献357

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部